Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125762303 | 12576230 | 3 | F | 201606 | 20160810 | 20160720 | 20160817 | EXP | IE-JNJFOC-20160710810 | JANSSEN | 80.01 | YR | E | F | Y | 0.00000 | 20160817 | CN | IE | IE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125762303 | 12576230 | 1 | PS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | N | FHS3MF | 125261 | 45 | MG | SOLUTION FOR INJECTION | |||||
| 125762303 | 12576230 | 2 | C | BISOPROLOL | BISOPROLOL | 1 | Oral | 0 | 2.5 | MG | UNSPECIFIED | QD | |||||||
| 125762303 | 12576230 | 3 | C | NORTEM | 2 | Oral | 0 | 10 | MG | UNSPECIFIED | QD | ||||||||
| 125762303 | 12576230 | 4 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | NIGHT | 0 | 5 | MG | UNSPECIFIED | |||||||
| 125762303 | 12576230 | 5 | C | ESCITALOPRAM | ESCITALOPRAM OXALATE | 1 | Oral | 0 | 10 | MG | UNSPECIFIED | QD | |||||||
| 125762303 | 12576230 | 6 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 0 | 10 | MG | UNSPECIFIED | QD | |||||||
| 125762303 | 12576230 | 7 | C | LYRICA | PREGABALIN | 1 | Oral | 0 | 75 | MG | UNSPECIFIED | QD | |||||||
| 125762303 | 12576230 | 8 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | 0 | 5 | MG | UNSPECIFIED | QD | |||||||
| 125762303 | 12576230 | 9 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | 5 | MG | UNSPECIFIED | QD | |||||||
| 125762303 | 12576230 | 10 | C | GALFER | IRON | 1 | Oral | 0 | 305 | MG | UNSPECIFIED | QD | |||||||
| 125762303 | 12576230 | 11 | C | CALCICHEW | CALCIUM CARBONATE | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 125762303 | 12576230 | 12 | C | DICLOFENAC | DICLOFENAC | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 125762303 | 12576230 | 13 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | PRN AS REQUIRED | 0 | 1 | G | UNSPECIFIED | |||||||
| 125762303 | 12576230 | 14 | C | ALENDRONIC | 2 | Oral | NIGHT | 0 | 70 | MG | UNSPECIFIED | QD | |||||||
| 125762303 | 12576230 | 15 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | NIGHT | 0 | 40 | MG | UNSPECIFIED | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125762303 | 12576230 | 1 | Psoriatic arthropathy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125762303 | 12576230 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125762303 | 12576230 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125762303 | 12576230 | 1 | 201605 | 0 |